Ben Comer on Muck Rack

Ben Comer

Verified
Pittsburgh
As seen in: Life Science Leader, MM+M, Citeline, Medtech Insight, Clinical Leader, Bioprocess Online, Pharmaceutical Online, Outsourced Pharma, Advancing RNA
Chief Editor at Life Science Leader
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ben

Contact Ben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Where Are They Now? Life Science Cares

|
By Ben Comer Verified
| Life Science Leader Verified
By Ben Comer, Chief Editor, Life Science Leader Sarah MacDonald, CEO, Life Science Cares Then: Back in 2020, former Life Science Leader chief editor Rob Wright spoke with biopharma veteran Rob Perez about founding Life Science Cares, an industry philanthropic organization and platform for aggregating resources to impact poverty in communities where members operate.
Open in Who Shared Issue with article?

On The Road: The Business Of Biotech In San Francisco For JPM2026

|
By Ben Comer Verified
| Life Science Leader Verified
By Ben Comer, Chief Editor, Life Science Leader Each January, the J.P. Morgan Healthcare Conference helps to set the biopharmaceutical industry agenda for the coming year, and more suits can be seen on the streets of San Francisco than during any other week of the year. There were fewer ties in 2026 — a multiyear decline — but still plenty of suits.
Open in Who Shared Issue with article?

12.13.25 -- Outsourced Pharma Best Of November

|
By Kat Kozyrytska, Ryan Murray, Ben Comer Verified, Brandon Haigh, Louis Garguilo Verified
| Outsourced Pharma
NOVEMBER'S BEST FEATURED EDITORIAL The Moral Economics Of Precision Medicine The most complex and expensive drugs to develop often target terrible diseases that affect only a small number of people and will never reach blockbuster status. Takeda Reimagines Biopharma Quality For The Digital Age Artificial intelligence, even in its current form, is especially good at synthesizing large data sets. Here's how one company makes the most of it.
Open in Who Shared Issue with article?
See all 155 licensed articles (176 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified